Free Trial
LON:GSK

GSK (GSK) Share Price, News & Analysis

GSK logo
GBX 1,503.50 -14.00 (-0.92%)
As of 09/12/2025 12:38 PM Eastern

About GSK Stock (LON:GSK)

Key Stats

Today's Range
1,500.50
1,531
50-Day Range
1,344
1,517.49
52-Week Range
1,242.50
1,649.25
Volume
6.15 million shs
Average Volume
12.31 million shs
Market Capitalization
£60.56 billion
P/E Ratio
1,818.02
Dividend Yield
0.04%
Price Target
GBX 1,637.50
Consensus Rating
Hold

Company Overview

GSK Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

GSK MarketRank™: 

GSK scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GSK has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for GSK is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    GSK has only been the subject of 4 research reports in the past 90 days.

  • Read more about GSK's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GSK is 1,818.02, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 280.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GSK is 1,818.02, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 75.40.

  • Price to Earnings Growth Ratio

    GSK has a PEG Ratio of 1.24. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    GSK has a P/B Ratio of 4.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GSK.
  • Dividend Leadership

    GSK is a leading dividend payer. It pays a dividend yield of 4.22%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    GSK does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of GSK is 74.97%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about GSK's dividend.
  • Short Interest

    There is no current short interest data available for GSK.
  • News Sentiment

    GSK has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for GSK this week, compared to 6 articles on an average week.
  • Search Interest

    42 people have searched for GSK on MarketBeat in the last 30 days. This is an increase of 5% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GSK insiders have bought more of their company's stock than they have sold. Specifically, they have bought £27,699.31 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    Only 0.20% of the stock of GSK is held by insiders.

  • Percentage Held by Institutions

    56.95% of the stock of GSK is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about GSK's insider trading history.
Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GSK Stock News Headlines

Insider Buying: GSK (LON:GSK) Insider Purchases 8 Shares of Stock
Kepler Capital Maintains a Hold Rating on GSK plc (GSK)
College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett.tc pixel
Julie Brown Purchases 8 Shares of GSK (LON:GSK) Stock
Emma Walmsley Purchases 9 Shares of GSK (LON:GSK) Stock
GSK Executives Acquire Shares Under Reward Plan
See More Headlines

GSK Stock Analysis - Frequently Asked Questions

GSK's stock was trading at GBX 1,346.50 at the start of the year. Since then, GSK stock has increased by 11.7% and is now trading at GBX 1,503.50.

GSK plc (LON:GSK) issued its quarterly earnings data on Wednesday, July, 30th. The company reported $75.30 earnings per share for the quarter. GSK had a trailing twelve-month return on equity of 18.08% and a net margin of 8.02%.

Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that GSK investors own include AstraZeneca (AZN), Vodafone Group Public (VOD), Lloyds Banking Group (LLOY), Secure Trust Bank (STB), Barclays (BARC), Meta Platforms (META) and Intel (INTC).

Company Calendar

Last Earnings
7/30/2025
Today
9/14/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:GSK
CIK
N/A
Fax
N/A
Employees
70,212
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 2,100
Low Price Target
GBX 1,400
Potential Upside/Downside
+8.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 0.83
Trailing P/E Ratio
1,818.02
Forward P/E Ratio
8.54
P/E Growth
1.24
Net Income
£2.50 billion
Net Margins
8.02%
Pretax Margin
N/A
Return on Equity
18.08%
Return on Assets
9.56%

Debt

Debt-to-Equity Ratio
114.64
Current Ratio
0.81
Quick Ratio
0.73

Sales & Book Value

Annual Sales
£31.63 billion
Price / Sales
1.91
Cash Flow
GBX 184.58 per share
Price / Cash Flow
8.15
Book Value
GBX 329.73 per share
Price / Book
4.56

Miscellaneous

Outstanding Shares
4,027,664,000
Free Float
N/A
Market Cap
£60.56 billion
Optionable
Not Optionable
Beta
0.31
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (LON:GSK) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners